These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18797599)

  • 1. [News options and preparations in growth hormone therapy].
    Aguiar-Oliveira MH; Meneguz-Moreno RA; Nascimento-Junior AC
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):917-24. PubMed ID: 18797599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
    Péter F; Bidlingmaier M; Savoy C; Ji HJ; Saenger PH
    J Clin Endocrinol Metab; 2012 Feb; 97(2):400-7. PubMed ID: 22162481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel long-acting GH preparations.
    Doknic M; Stojanovic M; Popovic V
    Pediatr Endocrinol Rev; 2014 Dec; 12(2):206-12. PubMed ID: 25581986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth hormone deficiency in adulthood: how to diagnose and when to treat?].
    Jallad RS; Bronstein MD
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):861-71. PubMed ID: 18797594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
    Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical considerations in using growth hormone therapy in growth hormone deficiency.
    Ranke MB
    Endocr Dev; 2010; 18():83-91. PubMed ID: 20523019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Acting Growth Hormone Preparations - Current Status and Future Considerations.
    Miller BS; Velazquez E; Yuen KCJ
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2121-33. PubMed ID: 31676901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status of long-acting-growth hormone preparations--2015.
    Høybye C; Cohen P; Hoffman AR; Ross R; Biller BM; Christiansen JS;
    Growth Horm IGF Res; 2015 Oct; 25(5):201-6. PubMed ID: 26187188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study.
    Sävendahl L; Maes M; Albertsson-Wikland K; Borgström B; Carel JC; Henrard S; Speybroeck N; Thomas M; Zandwijken G; Hokken-Koelega A
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E213-7. PubMed ID: 22238393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for growth hormone therapy in children.
    Kirk J
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method.
    Migliaretti G; Ditaranto S; Guiot C; Vannelli S; Matarazzo P; Cappello N; Stura I; Cavallo F
    J Endocrinol Invest; 2018 Jul; 41(7):839-848. PubMed ID: 29318462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy with norditropin ( somatropin ) in growth hormone deficiency.
    Pawlikowska-Haddal A
    Expert Opin Biol Ther; 2013 Jun; 13(6):927-32. PubMed ID: 23662811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
    Szczepańska J; Urban M; Głowińska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency.
    Conway GS; Szarras-Czapnik M; Racz K; Keller A; Chanson P; Tauber M; Zacharin M;
    Eur J Endocrinol; 2009 Jun; 160(6):899-907. PubMed ID: 19324976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
    Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative.
    Chen SC; Bryce J; Chen M; Charmandari E; Choi JH; Dou X; Gong C; Hamza R; Harvey J; Hoffman AR; Horikawa R; Johannson G; Jorge AAL; Miller BS; Roehrich S; Sävendahl L; Tseretopoulou X; Vitali D; Wajnrajch M; Ahmed SF
    Horm Res Paediatr; 2024; 97(4):365-373. PubMed ID: 37703843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children.
    Bakker B; Frane J; Anhalt H; Lippe B; Rosenfeld RG
    J Clin Endocrinol Metab; 2008 Feb; 93(2):352-7. PubMed ID: 18000092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
    Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
    Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.